These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3397227)

  • 21. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients.
    McCormick S; Olin J; Brotman AW
    J Clin Psychiatry; 1990 Sep; 51(9):383-4. PubMed ID: 2211550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine.
    Johnson A; Giuffre RM; O'Malley K
    Can J Psychiatry; 1996 Mar; 41(2):102-6. PubMed ID: 8705955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract]   [Full Text] [Related]  

  • 24. Side effects of methylphenidate and desipramine alone and in combination in children.
    Pataki CS; Carlson GA; Kelly KL; Rapport MD; Biancaniello TM
    J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1065-72. PubMed ID: 8407753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of desipramine on autonomic control of the heart.
    Walsh BT; Giardina EG; Sloan RP; Greenhill L; Goldfein J
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):191-7. PubMed ID: 8150790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
    Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder.
    Gualtieri CT; Keenan PA; Chandler M
    J Clin Psychopharmacol; 1991 Jun; 11(3):155-9. PubMed ID: 2066453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of adult ADHD and comorbid depression.
    Spencer TJ
    CNS Spectr; 2008 May; 13(5 Suppl 8):14-6. PubMed ID: 18567134
    [No Abstract]   [Full Text] [Related]  

  • 29. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
    Biederman J; Baldessarini RJ; Goldblatt A; Lapey KA; Doyle A; Hesslein PS
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):805-13. PubMed ID: 8340302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine.
    Fernandez F; Levy JK; Samley HR; Pirozzolo FJ; Lachar D; Crowley J; Adams S; Ross B; Ruiz P
    Int J Psychiatry Med; 1995; 25(1):53-67. PubMed ID: 7649718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Kerman K; Steingard R; Wilens T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):354-60. PubMed ID: 8444765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder.
    Overtoom CC; Verbaten MN; Kemner C; Kenemans JL; van Engeland H; Buitelaar JK; van der Molen MW; van der Gugten J; Westenberg H; Maes RA; Koelega HS
    Behav Brain Res; 2003 Oct; 145(1-2):7-15. PubMed ID: 14529800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute distress after switch from Norpramin to generic desipramine.
    Rosenbaum JF; Falk WE; Gastfriend DR; Gross CC; Pollack MH; Tesar GE; Weilburg JB
    Am J Psychiatry; 1989 Jan; 146(1):122. PubMed ID: 2912233
    [No Abstract]   [Full Text] [Related]  

  • 36. Desipramine in the treatment of attention deficit disorder in adolescents.
    Gastfriend DR; Biederman J; Jellinek MS
    Psychopharmacol Bull; 1985; 21(1):144-5. PubMed ID: 3983334
    [No Abstract]   [Full Text] [Related]  

  • 37. Adult attention deficit hyperactivity disorder and desipramine.
    Magee R; Maier D; Reesal RT
    Can J Psychiatry; 1992 Mar; 37(2):148-9. PubMed ID: 1562962
    [No Abstract]   [Full Text] [Related]  

  • 38. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children.
    Garfinkel BD; Wender PH; Sloman L; O'Neill I
    J Am Acad Child Psychiatry; 1983 Jul; 22(4):343-8. PubMed ID: 6875128
    [No Abstract]   [Full Text] [Related]  

  • 39. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK
    Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
    [No Abstract]   [Full Text] [Related]  

  • 40. Allergic skin eruption with desipramine treatment.
    Joffe RT; Richter MA
    Can J Psychiatry; 1987 Nov; 32(8):695-6. PubMed ID: 2961432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.